2023-03-09 08:37:13 ET
- Genetic medicines company, Homology Medicines ( NASDAQ: FIXX ) announced that Julie Jordan, M.D., has been promoted to Chief Medical Officer.
- Previously, Dr. Jordan held the role of senior VP, Head of Clinical Development and Operations, at Homology, and she has been instrumental in advancing Homology’s gene editing and gene therapy clinical programs.
- Prior to Homology, Dr. Jordan was responsible for clinical and scientific development activities at Cerevel Therapeutics, including global trials for schizophrenia, focal epilepsy and anxiety disorder.
For further details see:
Homology Medicines gets new chief medical officer